Center for Sepsis Control and Care, Germany
7
0
0
6
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 60/100
14.3%
1 terminated/withdrawn out of 7 trials
85.7%
-0.8% vs industry average
14%
1 trials in Phase 3/4
33%
2 of 6 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (7)
Albumin Replacement Therapy in Septic Shock
Role: collaborator
(1,3)-β-D-glucan Based Diagnosis of Invasive Candida Infection in Sepsis
Role: lead
Quality Improvement in Infection COntrol and Sepsis Management in MOdel Regions
Role: lead
Structured Psychoeducation for Unemployed Adolescents With Extreme Obesity in a Multicenter Observational Study Focusing on Feasibility
Role: collaborator
Medical Education for Sepsis Source Control and Antibiotics
Role: lead
End-of-life Decision-making in Patients With Sepsis-related Organ Failure
Role: lead
Family Satisfaction (FS) in the Intensive Care Unit
Role: lead
All 7 trials loaded